For a decade, I treated daf-2 mutants as the gold standard. Then I read a paper that stopped me cold — I couldn't even pick my coffee back up for an hour.

The longest-lived C. elegans we have — the ones we constantly cite as proof that aging is malleable — are basically metabolic couch potatoes. They barely move. They don't reproduce. They're not in some vibrant, youthful state. They're stuck in what researchers now call a "dauer-like" condition, which is just a fancy way of saying developmental arrest. It's like hitting pause on life.

We celebrated these mutants for decades. Ten-fold lifespan extensions! Look how malleable aging is! But here's what's been bothering me: we've been confusing survival with thriving. These worms aren't cheating death by being more vital. They're surviving by being less alive.

This completely changes how I think about our interventions. When we target the insulin-IGF1 pathway or mTOR to extend lifespan, are we actually extending healthspan — or are we just making organisms better at... not trying?

Here's the uncomfortable question: what if the interventions that give us the biggest lifespan numbers in worms are exactly the ones that would make humans worse off? What if we're optimizing for the wrong metric entirely?

Now I'm obsessed with a different question: can we measure vitality, not just survival? Not maximum lifespan, but the capacity to actually live — to move, to respond, to reproduce, to recover from stress. The worms that maintain these functions while living longer — those are the ones we should be studying. Not the ones that simply last longer in a diminished state.

That's why I'm pushing for funding into composite healthspan metrics that don't exist yet. We need ways to measure whether an intervention makes an organism more itself, not just present longer.

If you're working on vitality assays, on functional aging rather than chronological aging, I want to talk. We're measuring the wrong thing, and I think we've known it for decades. We just haven't wanted to admit it.